Blog
ProPetro Holding Posts Narrower-Than-Expected Q1 Loss, Sales Beat
ProPetro Holding Corp. PUMP reported first-quarter 2026 adjusted loss per share of 3 cents, narrower than the Zacks Consensus Estimate of a loss of 12 cents. This performance was primarily backed by
Delek US Q1 Earnings & Revenues Beat Estimates, Adjusted EBITDA Up Y/Y
Delek US Holdings, Inc. DK reported first-quarter 2026 adjusted earnings of 8 cents per share, in contrast to the Zacks Consensus Estimate of a loss of $1.56. The bottom line also improved 103.4%
Best Momentum Stock to Buy for May 4th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 4th:
Seagate Technology STX: This company, which engages in the provision of data storage
Pre-Markets Mixed to Begin New Trading Week
Monday, May 4th, 2026Pre-market futures are mixed to kick off a new week, with another more-than-impressive earnings season from AI-related Tech keeping the Nasdaq in the green at this hour, while
TransDigm to Report Q2 Results: What's in Store for the Stock?
TransDigm Group Incorporated TDG is slated to report second-quarter fiscal 2026 results on May 5, before market open. The company delivered an earnings surprise of 2.62% in the last reported
Analysts Estimate Ramaco Resources (METC) to Report a Decline in Earnings: What to Look Out for
The market expects Ramaco Resources (METC) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus
CI&T Inc. (CINT) Reports Next Week: Wall Street Expects Earnings Growth
CI&T Inc. (CINT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives
Catalyst Pharmaceutical (CPRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Catalyst Pharmaceutical (CPRX) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
The market expects Hims & Hers Health, Inc. (HIMS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known
BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?
BioXcel Therapeutics, Inc. (BTAI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known
Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know
The market expects Aquestive Therapeutics (AQST) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known
AST SpaceMobile, Inc. (ASTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
The market expects AST SpaceMobile, Inc. (ASTS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known
Agenus (AGEN) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Agenus (AGEN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a
Telos Corporation (TLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Telos Corporation (TLS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Earnings Preview: Mosaic (MOS) Q1 Earnings Expected to Decline
The market expects Mosaic (MOS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is
Ovintiv (OVV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Ovintiv (OVV) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is
Constellation Energy Corporation (CEG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Constellation Energy Corporation (CEG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known
Babcock & Wilcow Enterprises (BW) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
The market expects Babcock & Wilcow Enterprises (BW) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known
Aecom Technology (ACM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Aecom Technology (ACM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Earnings Preview: United Parks & Resorts (PRKS) Q1 Earnings Expected to Decline
The market expects United Parks & Resorts (PRKS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known
Barrick Mining (B) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Barrick Mining (B) reports results for the quarter ended March 2026. While this widely-known consensus outlook is
Integra Resources Corp. (ITRG) Earnings Expected to Grow: Should You Buy?
Integra Resources Corp. (ITRG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Inter & Co. Inc. (INTR) Earnings Expected to Grow: Should You Buy?
Inter & Co. Inc. (INTR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook
Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Harrow (HROW) reports results for the quarter ended March 2026. While this widely-known consensus outlook is
Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Heron Therapeutics (HRTX) reports results for the quarter ended March 2026. While this widely-known consensus outlook